Biotech company Indoor Biotechnologies, co-founded by a Cardiff University alumnus, has developed a test for coronavirus T cells which can potentially provide longer-term immunity to the virus than antibodies.
The company’s trials found some people who had coronavirus but tested negative for antibodies went on to test positive for T cells – meaning more people may have some immunity than previously thought – and for longer. Hundreds of people who tested positive for coronavirus in the past have been tested – with a focus on healthcare workers – to check whether they had developed T cells. The company has also tested people who have never had coronavirus, to ensure its accuracy.
Keine Kommentare:
Kommentar veröffentlichen